Clinical characteristics and palliative needs of patients with non-oncological liver failure care in a palliative care service
Article Sidebar
Main Article Content
Abstract
Liver failure is the fourth leading cause of death in Mexico. Treatment is exclusively symptomatic support, since the only curative therapy is liver transplantation, and Mexico is one of the countries with the fewest transplants worldwide, making the inclusion of early palliative care vital. The aim of this article is to describe the clinical characteristics and palliative needs of patients with non-oncologic liver failure in the palliative care service of the Hospital Gea González. An observational and retrospective study was carried out, of 80 records of patients with non-oncologic liver failure, attended from January 2021 to June 2023. All patients required palliative care, according to the palliative needs scale (NECPAL), and 80% had advanced chronic disease criteria, the main etiology being alcoholism. The need to include an early palliative care program is justified, which will have a lesser economic, social and psychological impact on Mexican families.
Downloads
PLUMX Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Medicina y Ética is distributed under a Creative Commons License Atribución-NoComercial-CompartirIgual 4.0 Internacional.
The author keeps the property rights with no restriction whatsoever and guarantees the magazine the right to be the first publication of the work. The author is free to deposit the published version in any other medium, such as an institutional archive or on his own website.
References
Rodríguez M, Valencia R, Altamirano J. Etiología y complicaciones de la cirrosis hepática en el Hospital Juárez de México. Rev Hosp Jua Mex. 2008; 75(4):257-263. Disponible en: https://biblat.unam.mx/es/revista/revista-del-hospital-juarez-de-mexico/articulo/etiologia-y-complicaciones-de-la-cirrosis-hepatica-en-el-hospital-juarez-de-mexico
Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008; 371(9615):838-51. https://pubmed.ncbi.nlm.nih.gov/18328931/ DOI: https://doi.org/10.1016/S0140-6736(08)60383-9
Fernández J, Arroyo V. Insuficiencia hepática crónica: una entidad clínica necesitada de investigadores. Gastroenterología y Hepatología. 2010; 33:619–20. https://doi.org/10.1016/j.gastrohep.2010.08.003 DOI: https://doi.org/10.1016/j.gastrohep.2010.08.003
Flores-García N, Dirac H, Kershenobich-Stalnikowitz D. La carga de la enferme- dad por cirrosis hepática en México. Gac. Méd. Méx [Internet]. 2023; 159(6):509- 516. https://doi.org/10.24875/gmm.23000370 DOI: https://doi.org/10.24875/GMM.23000370
Tapper E, Parikh N. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018; 362:k2817. https://www.bmj.com/content/362/bmj.k2817 DOI: https://doi.org/10.1136/bmj.k2817
Ratib S, Fleming K, Crooks C, Aithal G, West J. 1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study. J Hepatol. 2014; 60(2):282-9. https://doi.org/10.1016/j.jhep.2013.09.027 DOI: https://doi.org/10.1016/j.jhep.2013.09.027
García L, González F, Moreno-Otero R. Liver cirrosis. Medicine (Spain). 2012; 11(11):625–33. https://dialnet.unirioja.es/servlet/articulo?codigo=3927342 DOI: https://doi.org/10.1016/S0304-5412(12)70359-1
Roesch-Dietlen F, González-Santes M, Sánchez-Maza Y, Díaz-Roesch F, Ca- no-Contreras A, Amieva-Balmori M, García-Zermeño K, Salgado-Vergara L, Remes-Troche J, Ortigoza-Gutiérrez S. Influence of socioeconomic and cultural factors in the etiology of cirrhosis of the liver. Rev Gastroenterol Mex (Engl Ed). 2021; 86(1):28-35. https://doi.org/10.1016/j.rgmx.2020.01.002 DOI: https://doi.org/10.1016/j.rgmxen.2020.01.004
Campos-Varela I, Castells L. Puntuaciones de pronóstico de la cirrosis [Prognostic scores of cirrhosis]. Gastroenterol Hepatol. 2008; 31(7):439-46. https://doi.org/10.1157/13125591 DOI: https://doi.org/10.1157/13125591
Kamath P, Kim W. Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007; 45(3):797-805. https://doi.org/10.1002/hep.21563 DOI: https://doi.org/10.1002/hep.21563
Verma M, Kosinski A, Volk M, Taddei T, Ramchandran K, Bakitas M. Introducing palliative care within the treatment of end-stage liver disease: the study protocol of a cluster randomized controlled trial. J Palliat Med. 2019; 22(S1):S34–43. https://doi.org/10.1089/jpm.2019.0121 DOI: https://doi.org/10.1089/jpm.2019.0121
Langberg K, Kapo J, Taddei T. Palliative care in decompensated cirrhosis: a review. Liver International. Blackwell Publishing Ltd. 2018; 38:768–75. https://doi.org/10.1111/liv.13620 DOI: https://doi.org/10.1111/liv.13620
Patel A, Walling A, May F, Saab S, Wenger N. Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life. Clinical Gastroenterology and Hepatology. 2017; 15(10):1612-1619. https://doi.org/10.1016/j.cgh.2017.01.030 DOI: https://doi.org/10.1016/j.cgh.2017.01.030
Larson A. Palliative care for patients with end-stage liver disease. Curr Gastroenterol Rep. 2015; 17(5):440. https://doi.org/10.1007/s11894-015-0440-6 DOI: https://doi.org/10.1007/s11894-015-0440-6
Picco G, Escalada H, Ríos R, Lama M, Martínez M. Soporte paliativo en pacientes con enfermedad hepática avanzada: enfocar a necesidades más que a pronóstico. FMC. 2018; 25(4):237–45. https://www.fmc.es/es-soporte-paliativo-en-pacientes-con-enfer-articulo-S1134207218300628 DOI: https://doi.org/10.1016/j.fmc.2017.06.008
Troncoso J, Morales-Meyer T, Villarroel L, Turrillas P, Rodríguez-Nuñez A. Adaptation and validation in Chile of the patient identification instrument needing palliative care: NECPAL-CCOMS-ICO 3.1©. Aten Primaria. 2021; 53(4). https://doi.org/10.1016/j.aprim.2021.101994 DOI: https://doi.org/10.1016/j.aprim.2021.101994
Gómez-Batiste X MMMBCAJVLCXEJEJFM. Proyecto NECPAL CCOMS-ICO©: Instrumento para la identificación de personas en situación de enfermedad crónica avanzada y necesidades de atención paliativa en servicios de salud y social. Centro Colaborador de la OMS para Programas Públicos de Cuidados Paliativos. Institut Català d’Oncologia. Disponible en: https://ico.gencat.cat/web/.content/minisite/ico/professionals/documents/qualy/arxius/doc_necpal_ccoms-ico_instrumento_esp_vweb_vff.pdf
Jepsen P, Vilstrup H, Andersen PK, Lash TL, Sørensen HT. Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology. 2008; 48(1):214-20. https://doi.org/10.1002/hep.22341 DOI: https://doi.org/10.1002/hep.22341
Vaz J, Eriksson B, Strömberg U, Buchebner D, Midlöv P. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study. BMC Gastroenterol. 2020; 20(1):84. https://doi.org/10.1186/s12876-020-01239-6 DOI: https://doi.org/10.1186/s12876-020-01239-6
Campollo O, Valencia J. J, Berumen A, Pérez M. A, Panduro A, Segura J. Características epidemiológicas de la cirrosis hepática en el Hospital Civilde Guadalajara. Salud Pública de México [Internet]. 1997; 39(3):195-200. https://doi.org/10.1590/S0036-36341997000300004 DOI: https://doi.org/10.1590/S0036-36341997000300004
Bustíos C, Dávalos M, Román R, Zumaeta E. Características Epidemiológicas y Clínicas de la Cirrosis Hepática en la Unidad de Hígado del HNERM Es-Salud. Rev. gastroenterol. Perú [Internet]. 2007; 27(3):238-245. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292007000300003
Leyva L, Palomino A, Quesada E, Oliva J, Yanes A. Epidemiological and clinical characteristics of patients with liver cirrhosis. Revista Cubana de Medicina Militar. el 13 de octubre de 2021; 50(4). Disponible en: https://www.medigraphic.com/cgibin/new/resumenI.cgi?IDARTICULO=112184
Buganza-Torio E, Montano-Loza A. Hospital mortality in cirrhotic patients at a tertiary care center in Latin America. Revista de Gastroenterología de México. Asociación Mexicana de Gastroenterología. 2017; 82:201–2. Disponible en: https://doi.org/10.1016/j.rgmxen.2017.04.006 DOI: https://doi.org/10.1016/j.rgmxen.2017.04.006
Funes Rosas W, Cabezas Gómez J. Sensibilidad de escalas como pronóstico y necesidades paliativas en adultos mayores con enfermedad no oncológica. Alerta, Revista Científica del Instituto Nacional de Salud. 2023; 6(2):157–64. Disponible en: https://camjol.info/index.php/alerta/article/view/15856 DOI: https://doi.org/10.5377/alerta.v6i2.15856